Market Cap 1.11B
Revenue (ttm) 255.87M
Net Income (ttm) -103.27M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -40.36%
Debt to Equity Ratio 0.00
Volume 650,700
Avg Vol 1,350,098
Day's Range N/A - N/A
Shares Out 73.83M
Stochastic %K 14%
Beta 1.62
Analysts Strong Sell
Price Target $20.62

Company Profile

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focu...

Industry: Health Information Services
Sector: Healthcare
Phone: 212 295 5800
Address:
1540 Broadway, 24th Floor, New York, United States
Niconicai
Niconicai Jul. 22 at 8:34 PM
$RXRX $ABCL $ABSI $SDGR $XBI After President Trump said on The Axios Show that AI drug discovery could bring “medical cures 25 years early,” the White House today unveiled the $5B+ Genesis Mission, with one of its flagship initiatives focused on accelerating drug discovery and clinical translation using AI, combining molecular, genomic, phenotypic, clinical, and real-world data. AI drug discovery is clearly becoming a national priority.
2 · Reply
Trader_Ty
Trader_Ty Jul. 21 at 1:36 PM
$SDGR dodged this one by happenstance . Remains on WL , see if it can hold the weekly EMAs
1 · Reply
bambus3001
bambus3001 Jul. 21 at 12:24 PM
$SDGR Alle zittrigen Aktienvetkäufe werden alle sofort gekauft. Da spielt dich was ab hinter den kulissen .Bin mir sehr sicher dabei und kaufe gerne mehr dazu bei den Preisen !!
0 · Reply
BB_88_
BB_88_ Jul. 20 at 2:53 PM
$SDGR in 15.03 needs to cross 15.39
0 · Reply
BB_88_
BB_88_ Jul. 20 at 2:43 PM
$SDGR in here
0 · Reply
bambus3001
bambus3001 Jul. 17 at 5:56 PM
$SDGR Ki grade nicht angesagt Schrodinger spielt aber eine Liga der besonderen Art , Wissen ist Macht und Big Pharma will was vom Kuchen
0 · Reply
bambus3001
bambus3001 Jul. 16 at 3:38 PM
$SDGR 1mal durchtauschen einzelne Pakete für kleinen Bonus vermute Ich . Hoffentlich kein Buy out .
0 · Reply
madnessofcrowds
madnessofcrowds Jul. 16 at 3:18 PM
$SDGR bought some more 15.4 averaging up
0 · Reply
bambus3001
bambus3001 Jul. 15 at 6:27 PM
$SDGR Platz bis 26 in der nächsten Etappe , Vermute der Umsatz wird positiv überraschen . Für mich ein Topp Investment für sehr langen Zeitraum ,wenn kein Buy out kommt. Heisse Perle sehr günstig mit dem Inputt
0 · Reply
Trader_Ty
Trader_Ty Jul. 15 at 5:24 PM
$SDGR Stock is under the downtrend but holding nicely over the EMAs ... that is interesting to me while a lot of other names are breaking down. Why hasn't this broken down? Is my train of thought (💪) ... as always, it could fail.
0 · Reply
Latest News on SDGR
Schrödinger Transcript: AGM 2026

Jun 22, 2026, 12:00 PM EDT - 4 weeks ago

Schrödinger Transcript: AGM 2026


Schrödinger Earnings Call Transcript: Q1 2026

May 5, 2026, 4:30 PM EDT - 2 months ago

Schrödinger Earnings Call Transcript: Q1 2026


Schrödinger Earnings release: Q1 2026

May 5, 2026, 4:30 PM EDT - 2 months ago

Schrödinger Earnings release: Q1 2026


Schrödinger Quarterly report: Q1 2026

May 5, 2026, 4:30 PM EDT - 2 months ago

Schrödinger Quarterly report: Q1 2026


Schrödinger Slides: Q1 2026

May 5, 2026, 4:30 PM EDT - 2 months ago

Schrödinger Slides: Q1 2026


Schrödinger Reports First Quarter 2026 Financial Results

May 5, 2026, 4:05 PM EDT - 2 months ago

Schrödinger Reports First Quarter 2026 Financial Results


Schrödinger to Participate in Upcoming Investor Conferences

May 4, 2026, 8:30 AM EDT - 2 months ago

Schrödinger to Participate in Upcoming Investor Conferences


Schrödinger Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 3 months ago

Schrödinger Proxy statement: Proxy filing


Schrödinger Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 3 months ago

Schrödinger Proxy statement: Proxy filing


Schrodinger reports inducement grants under Nasdaq listing rule

2026-04-17T12:52:03.000Z - 3 months ago

Schrodinger reports inducement grants under Nasdaq listing rule


Schrodinger price target lowered to $20 from $25 at KeyBanc

2026-04-13T10:44:45.000Z - 3 months ago

Schrodinger price target lowered to $20 from $25 at KeyBanc


Schrodinger price target lowered to $13 from $18 at UBS

2026-03-17T12:40:30.000Z - 4 months ago

Schrodinger price target lowered to $13 from $18 at UBS


Schrodinger price target lowered to $20 from $24 at BofA

2026-02-26T14:49:36.000Z - 5 months ago

Schrodinger price target lowered to $20 from $24 at BofA


Schrodinger reports FY25 EPS ($1.41) vs. ($2.57) last year

2026-02-25T21:49:18.000Z - 5 months ago

Schrodinger reports FY25 EPS ($1.41) vs. ($2.57) last year


Schrödinger Earnings Call Transcript: Q4 2025

Feb 25, 2026, 4:30 PM EST - 5 months ago

Schrödinger Earnings Call Transcript: Q4 2025


Schrödinger Annual report: Q4 2025

Feb 25, 2026, 4:30 PM EST - 5 months ago

Schrödinger Annual report: Q4 2025


Schrödinger Earnings release: Q4 2025

Feb 25, 2026, 4:30 PM EST - 5 months ago

Schrödinger Earnings release: Q4 2025


Schrödinger Slides: Q4 2025

Feb 25, 2026, 4:30 PM EST - 5 months ago

Schrödinger Slides: Q4 2025


Schrodinger announces collaboration with Lilly TuneLab

2026-01-09T12:13:36.000Z - 6 months ago

Schrodinger announces collaboration with Lilly TuneLab

LLY


Schrodinger price target lowered to $24 from $33 at TD Cowen

2026-01-08T14:41:54.000Z - 6 months ago

Schrodinger price target lowered to $24 from $33 at TD Cowen


Schrodinger price target lowered to $25 from $28 at KeyBanc

2026-01-08T12:46:07.000Z - 6 months ago

Schrodinger price target lowered to $25 from $28 at KeyBanc


Schrodinger initiated with a Neutral at UBS

2026-01-07T13:27:32.000Z - 7 months ago

Schrodinger initiated with a Neutral at UBS


Schrodinger upgraded to Buy from Neutral at BofA

2025-12-15T11:25:26.000Z - 7 months ago

Schrodinger upgraded to Buy from Neutral at BofA


Schrödinger Earnings Call Transcript: Q3 2025

Nov 5, 2025, 4:30 PM EST - 9 months ago

Schrödinger Earnings Call Transcript: Q3 2025


Schrödinger Quarterly report: Q3 2025

Nov 5, 2025, 4:30 PM EST - 9 months ago

Schrödinger Quarterly report: Q3 2025


Schrödinger Earnings release: Q3 2025

Nov 5, 2025, 4:30 PM EST - 9 months ago

Schrödinger Earnings release: Q3 2025


Schrödinger Slides: Q3 2025

Nov 5, 2025, 4:30 PM EST - 9 months ago

Schrödinger Slides: Q3 2025


Schrödinger Reports Third Quarter 2025 Financial Results

Nov 5, 2025, 4:05 PM EST - 9 months ago

Schrödinger Reports Third Quarter 2025 Financial Results


Schrödinger Announces Discontinuation of SGR-2921 Program

Aug 14, 2025, 7:00 AM EDT - 1 year ago

Schrödinger Announces Discontinuation of SGR-2921 Program


Schrödinger Earnings Call Transcript: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Earnings Call Transcript: Q2 2025


Schrödinger Quarterly report: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Quarterly report: Q2 2025


Schrödinger Earnings release: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Earnings release: Q2 2025


Schrödinger Slides: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Slides: Q2 2025


Schrödinger Reports Second Quarter 2025 Financial Results

Aug 6, 2025, 4:05 PM EDT - 1 year ago

Schrödinger Reports Second Quarter 2025 Financial Results


Schrödinger Transcript: AGM 2025

Jun 18, 2025, 12:00 PM EDT - 1 year ago

Schrödinger Transcript: AGM 2025


Schrödinger Transcript: Status Update

Jun 12, 2025, 8:00 AM EDT - 1 year ago

Schrödinger Transcript: Status Update


Schrödinger Press release: Status Update

Jun 12, 2025, 8:00 AM EDT - 1 year ago

Schrödinger Press release: Status Update


Schrödinger Slides: Status Update

Jun 12, 2025, 8:00 AM EDT - 1 year ago

Schrödinger Slides: Status Update


Schrödinger Announces CFO Appointment

May 20, 2025, 6:30 AM EDT - 1 year ago

Schrödinger Announces CFO Appointment


Schrödinger Earnings Call Transcript: Q1 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Earnings Call Transcript: Q1 2025


Schrödinger Quarterly report: Q1 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Quarterly report: Q1 2025


Schrödinger Earnings release: Q1 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Earnings release: Q1 2025


Schrödinger Slides: Q1 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Slides: Q1 2025


Schrödinger Proxy statement: Proxy Filing

Apr 24, 2025, 8:00 AM EDT - 1 year ago

Schrödinger Proxy statement: Proxy Filing


Schrödinger Proxy statement: Proxy Filing

Apr 24, 2025, 8:00 AM EDT - 1 year ago

Schrödinger Proxy statement: Proxy Filing


Niconicai
Niconicai Jul. 22 at 8:34 PM
$RXRX $ABCL $ABSI $SDGR $XBI After President Trump said on The Axios Show that AI drug discovery could bring “medical cures 25 years early,” the White House today unveiled the $5B+ Genesis Mission, with one of its flagship initiatives focused on accelerating drug discovery and clinical translation using AI, combining molecular, genomic, phenotypic, clinical, and real-world data. AI drug discovery is clearly becoming a national priority.
2 · Reply
Trader_Ty
Trader_Ty Jul. 21 at 1:36 PM
$SDGR dodged this one by happenstance . Remains on WL , see if it can hold the weekly EMAs
1 · Reply
bambus3001
bambus3001 Jul. 21 at 12:24 PM
$SDGR Alle zittrigen Aktienvetkäufe werden alle sofort gekauft. Da spielt dich was ab hinter den kulissen .Bin mir sehr sicher dabei und kaufe gerne mehr dazu bei den Preisen !!
0 · Reply
BB_88_
BB_88_ Jul. 20 at 2:53 PM
$SDGR in 15.03 needs to cross 15.39
0 · Reply
BB_88_
BB_88_ Jul. 20 at 2:43 PM
$SDGR in here
0 · Reply
bambus3001
bambus3001 Jul. 17 at 5:56 PM
$SDGR Ki grade nicht angesagt Schrodinger spielt aber eine Liga der besonderen Art , Wissen ist Macht und Big Pharma will was vom Kuchen
0 · Reply
bambus3001
bambus3001 Jul. 16 at 3:38 PM
$SDGR 1mal durchtauschen einzelne Pakete für kleinen Bonus vermute Ich . Hoffentlich kein Buy out .
0 · Reply
madnessofcrowds
madnessofcrowds Jul. 16 at 3:18 PM
$SDGR bought some more 15.4 averaging up
0 · Reply
bambus3001
bambus3001 Jul. 15 at 6:27 PM
$SDGR Platz bis 26 in der nächsten Etappe , Vermute der Umsatz wird positiv überraschen . Für mich ein Topp Investment für sehr langen Zeitraum ,wenn kein Buy out kommt. Heisse Perle sehr günstig mit dem Inputt
0 · Reply
Trader_Ty
Trader_Ty Jul. 15 at 5:24 PM
$SDGR Stock is under the downtrend but holding nicely over the EMAs ... that is interesting to me while a lot of other names are breaking down. Why hasn't this broken down? Is my train of thought (💪) ... as always, it could fail.
0 · Reply
BB_88_
BB_88_ Jul. 15 at 4:24 PM
$SDGR expecting 15.8
0 · Reply
BB_88_
BB_88_ Jul. 15 at 4:01 PM
$SDGR here comes the crack
0 · Reply
BB_88_
BB_88_ Jul. 15 at 3:40 PM
$SDGR short 16.6 day trade only - market iffy
0 · Reply
Laddoom
Laddoom Jul. 15 at 4:36 AM
$SDGR Miles Wang, an OpenAI researcher whose work includes using AI to accelerate scientific and biological discovery, is leaving the ChatGPT maker to launch a new startup focused on developing AI models for drug discovery, according to four people with knowledge of his plans. Several other OpenAI researchers are expected to join the new company Goddamn this is turning into a startup space
0 · Reply
bambus3001
bambus3001 Jul. 13 at 2:59 PM
$SDGR Big Pharma sind alle dran interessiert, was Schrodinger an Daten und Technologien Besitztümer hat.Und so ganz Nebenbei entwickeln sie jetzt auch selber neue Medikamente. Tolle Zukunft diese Firma.!!!
0 · Reply
Trader_Ty
Trader_Ty Jul. 13 at 2:38 PM
$SDGR remains top candidate for a trade
0 · Reply
bambus3001
bambus3001 Jul. 13 at 2:13 PM
$SDGR Der Chart zeigt an ,wir werden steigen gen Norden
0 · Reply
madnessofcrowds
madnessofcrowds Jul. 11 at 10:58 AM
$SDGR holding up fine given all the turbulence in software land. have noticed big money buying it up huge at the open and at the close. clear signs of accumulation.
0 · Reply
Weber10
Weber10 Jul. 10 at 8:12 PM
$SDGR no question this is one of the most misunderstood companies in the marketplace and most of it is due to our CEO and his ego... I still believe and have a considerable amount invested here since late 2022 but my conviction has wavered some since then... we seem to be back on the right track and we do have some irons in the fire that can propel the SP significantly higher like the sale of our proprietary assets along with the rumored purchase of Structure Therapeutics (of which we have approximately 3% equity stake). At some point, value will be unlocked here and its absolutely ridiculous that we have a market cap less than RXRX and ABCL... they are cash burning bios that dilute their shareholders repeatedly... look at their share count compared to ours... Ramy should be given credit for that above all else... when we get re-rated is anyones guess but I believe that time is closer than we think.
0 · Reply
Hairoglyphics
Hairoglyphics Jul. 10 at 2:56 PM
https://www.cnbc.com/amp/2026/06/30/anthropic-launches-ai-drug-discovery-program-claude-science.html $PFE $ABBV $SDGR $MU $TELIF
0 · Reply
StockHunter75
StockHunter75 Jul. 9 at 11:23 PM
$SDGR 20+ coming soon
1 · Reply
bambus3001
bambus3001 Jul. 9 at 3:12 PM
$SDGR wer sich wohl hier eindeckt mit starken Käufen . Buy out oder topp News werden kommen .
0 · Reply